Skip to content

Radioguided Selective Neck Dissection for Staging and Treatment of Oral Cavity and Oropharyngeal Squamous Cell Carcinoma

Radioguided Selective Neck Dissection for Staging and Treatment of Oral Cavity and Oropharyngeal Squamous Cell Carcinoma

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03727594
Enrollment
50
Registered
2018-11-01
Start date
2016-01-31
Completion date
2021-01-31
Last updated
2018-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Cavity Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma

Brief summary

The purpose of the study is to assess the role of lymphoscintigraphy as a simple and widely accessible method with a favorable cost/benefit ratio in improving oral cavity and oropharyngeal squamous cell carcinoma staging and surgical appropriateness and implementing a tailored surgical approach to cervical lymph node dissection.

Interventions

None listed

Sponsors

University Hospital of Ferrara
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* accepted informed consent * preoperative histological diagnosis of oral cavity or oropharyngeal squamous cell carcinoma * patients fit to surgery of the primitive tumor and neck dissection (according to the general health condition and the clinical tumor stage)

Exclusion criteria

* rejected informed consent * patients not fit to surgery (according to the general health condition and the clinical tumor stage) * pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Number of patients with atypical lymphatic drainage of oral cavity and oropharyngeal squamous cell carcinoma identified through lymphoscintigraphy5 years
Number of metastasis or micrometastasis in the sentinel lymphnodes identified through immunofluorescence analysis of pancytokeratins5 years
Overall survival5 yearsPrognosis of radioguided neck dissection surgery compared to the standardized neck dissection traditionally performed in consideration of the site and the characteristics of the tumor and the clinical status of lymphnodes.
Disease-free survival5 yearsPrognosis of radioguided neck dissection surgery compared to the standardized neck dissection traditionally performed in consideration of the site and the characteristics of the tumor and the clinical status of lymphnodes.

Countries

Italy

Contacts

Primary ContactNicola Malagutti, MD
nicolamalagutti@gmail.com+393339011406

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026